ROARABLE
FREE $100K
My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Financials / NHI / news
BNL (55) HIW (65) IRT (46) SLG (59) ⌘ Pro Terminal →

Why NHI Stock advanced +0.39% Today — RQD Quant Desk Flash

$68.77 +0.39% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $68.69

National Health Investors Inc. (NHI) carries a Roarable Rating of D- (Sell) with 43/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • SELL / AVOID Cap $3.36B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on NHI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is NHI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, National Health Investors Inc. (NYSE: NHI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $68.77 (+0.39% 1D, market cap $3.36B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 8/20. Across 1097 tracked Financials issuers, NHI ranks #842 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does NHI compare to BNL and HIW in the Financials sector?
▼

Within the Financials sector (Real Estate Investment Trusts), NHI carries a Roarable D- (43/100 RQD), trailing P/E of 23.1x, gross margin of —, and ROIC of 9.3%. By comparison, BNL (Broadstone Net Lease Inc.) holds a D+ grade (55/100 RQD, P/E 34.6x, ROIC 2.3%, cap $3.38B) and HIW (Highwoods Properties Inc.) posts a C grade (65/100 RQD, P/E N/A, ROIC 18.3%, cap $3.45B). Among the 5-stock peer group, NHI leads on earnings multiple (23.1x) while HIW leads on capital efficiency (18.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for NHI?
▼

Per NHI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000877860), National Health Investors Inc. generated $80.1M in revenue (+47.1% YoY), $142.2M in net income, and -$57.5M in free cash flow against $2.80B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $68.69 (-0.12%)🧬 Disciplined Float (+1.08% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (43/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-6.7% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D-
025507510043
2-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw D- · Rk D+
Cash (8)Whales (6)SEC (13)Macro (8)CEO (8)
Each axis scored 0–20
12M PRICE TARGET CONE-6.7% Base Target
$96 Bull$64 Base$50 Bear
📬 FREE NHI RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NHI)Realized 20D OHLCV Swing Band: ±4.2%
Deterministic 5-Pillar Attribution (43/100 Composite)
🔍 WHY NHI SCORES 43/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (19% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning6/20 pts (-14 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-14 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
35
Grade E$65.36-0.7% Next Q
Q2 (-2Q)
38
Grade E$64.92+1.2% Next Q
Q3 (-1Q)
40
Grade D$65.68+4.7% Next Q
Current
43
Grade D-$68.77-6.7% Hist 90D α
Trajectory: E (35) → D- (43)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NHI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NHI currently carries a cautious 43/100 (D-) rating due to Whale & Options Positioning (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($67.75) and Max Pain ($72.21) forces dealer call-delta covering toward $95.95.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+1.08% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NHI• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “NHI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 43%NO 57%Trade / Inspect Odds →
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why NHI Stock advanced +0.39% Today — RQD Quant Desk Flash

National Health Investors Inc. (NHI) advanced +0.39% to $68.77, trading at 19% of its 52-week range ($63.51 – $91.38). Stretched risk/reward at 23x P/E (9% return on capital) under elevated 10-year interest-rate pressure.

  • ▸Technical Tape: Trading at 19% of its 52-week range ($63.51 – $91.38) with RSI-14 at 58.6 (BULLISH MOMENTUM).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±4.2% around $68.77 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable D- (Sell) backed by 52% gross margin and $0 annual free cash flow.
Live NHI Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NHI)

  • ✓Walkthrough of NHI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
NHI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -5.91%📐 HORIZONTAL RANGE
2026-11-04O $67.04H $68.77L $67.04C $68.77VOL 296.3K
RES: $88.09SUP: $60.74SMA50: $67.75SMA200: $76.19
$84.44$78.77$73.09$67.42$61.75RES $88.09SUP $60.74$68.772026-05-052026-06-182026-08-052026-09-212026-11-04
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NHI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NHI Butterfly Map → + Track NHI →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
16.9%/yr Implied 5Y Growth

vs. +47.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on NHI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NHI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for NHI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NHI)

Financials Rank #842 of 1097 ⚔️ BNL vs NHI Full Matrix →

1. Head-to-Head Financials Peer Comparison (NHI vs. BNL, HIW, IRT, SLG)

Industry: Real Estate Investment Trusts (172 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, National Health Investors Inc. (NHI) ranks #842 by composite RQD confidence (43/100, grade D-) and #342 by equity capitalization ($3.36B). Within this direct 5-issuer industry benchmark cohort, NHI leads on earnings valuation at 23.1x trailing P/E, while HIW leads on capital efficiency and profitability with 18.3% ROIC and — gross margin. HIW currently holds the highest overall quantitative score in the immediate peer group at 65/100 (C) compared with NHI at 43/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
NHI ACTIVE
National Health Investors Inc.
D- 43/100 23.1x — 9.3% +0.39% $3.36B Benchmark Subject
BNL
Broadstone Net Lease Inc.
D+ 55/100 34.6x — 2.3% +2.22% $3.38B /bnl-vs-nhi →
HIW
Highwoods Properties Inc.
C 65/100 — — 18.3% -1.60% $3.45B /hiw-vs-nhi →
IRT
Independence Realty Trust Inc.
D 46/100 61.7x — 1.6% -0.87% $3.52B /irt-vs-nhi →
SLG
SL Green Realty Corp
C- 59/100 — — 14.7% -2.16% $3.58B /slg-vs-nhi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000877860 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), National Health Investors Inc. (NHI) reported GAAP revenue of $80.1M (+47.1% vs. FY2024 revenue of $54.4M , and +64.0% cumulative change since FY2023) , GAAP net income of $142.2M, operating cash flow of $236.6M, and free cash flow of -$57.5M (-215.3% YoY). On the balance sheet, NHI closed FY2025 with $2.80B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $80.1M $142.2M $236.6M -$57.5M $2.80B —
FY2024 (FY) 2024-12-31 $54.4M $138.0M $207.8M $49.8M $2.61B —
FY2023 (FY) 2023-12-31 $48.8M $135.7M $184.4M $184.4M — —

3. NHI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NHI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, National Health Investors Inc. (NYSE: NHI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $68.77 (+0.39% 1D, market cap $3.36B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 8/20. Across 1097 tracked Financials issuers, NHI ranks #842 in composite RQD confidence.

How does NHI compare to BNL and HIW in the Financials sector?

Within the Financials sector (Real Estate Investment Trusts), NHI carries a Roarable D- (43/100 RQD), trailing P/E of 23.1x, gross margin of —, and ROIC of 9.3%. By comparison, BNL (Broadstone Net Lease Inc.) holds a D+ grade (55/100 RQD, P/E 34.6x, ROIC 2.3%, cap $3.38B) and HIW (Highwoods Properties Inc.) posts a C grade (65/100 RQD, P/E N/A, ROIC 18.3%, cap $3.45B). Among the 5-stock peer group, NHI leads on earnings multiple (23.1x) while HIW leads on capital efficiency (18.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NHI?

Per NHI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000877860), National Health Investors Inc. generated $80.1M in revenue (+47.1% YoY), $142.2M in net income, and -$57.5M in free cash flow against $2.80B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NHI trading relative to its 50-day, 200-day, and 52-week technical levels?

NHI last traded at $68.77 (+0.39% on volume of 330,199 shares), positioning the stock +1.51% above its 50-day simple moving average ($67.75) and -9.74% below its 200-day simple moving average ($76.19). Across its 52-week range of $63.51 to $91.38, NHI sits at the 18.9% percentile with a 14-day RSI of 58.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±4.2% ($65.88 to $71.66).

Direct Sub-Reports: NHI RQD Cockpit NHI 12M Forecast NHI Earnings & Move NHI Dividends & DRIP NHI Insiders & 13F NHI Whale Options NHI Profit Sankey NHI News & Why
ROARABLE RATING BRIEF • RQD 43/100 (D-) ✓ SEC XBRL & RQD VERIFIED

NHI — National Health Investors Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

National Health Investors Inc. (NHI) earns a live Roarable RQD composite score of 43/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $68.77 (+0.39% 1D, market capitalization $3.36B).

  • Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of 9.3%, gross margin of —, operating margin of —, and free cash flow yield of -1.75%.
  • Whale 13F & Options Flow (6/20) + Insider Conviction (8/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 5/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

National Health Investors Inc. (NHI) is a NYSE-listed issuer classified in the Financials sector and the Real Estate Investment Trusts industry,. Market capitalization is $3.3B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), National Health Investors Inc. (NHI) reported $80.1M in annual revenue (up from $54.4M in FY2024, +47.1% YoY) and $142.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($48.8M revenue, $135.7M net income) through FY2025, NHI scaled operating cash flow to $236.6M and free cash flow to -$57.5M, backed by $2.80B in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 43/100): Established market leader in Financials with deep daily trading liquidity. Free cash flow yield of -1.75% and institutional whale pillar of 6/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $63.51 – $91.38 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh 23.1x trailing P/E against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Supply_chain is NONE, butterfly_links is empty, and proprietary_signals is empty. No upstream or downstream dependencies, sector correlations, or second-order bottlenecks are identified in the source data. Investors should note that the absence of mapped links is itself a data limitation rather than evidence of independence.

  • Key Question #1: Can NHI sustain or expand its — operating margin and 9.3% ROIC against Real Estate Investment Trusts peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $80.1M and free cash flow of -$57.5M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is NHI's 19.4x forward P/E multiple to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

NHI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for National Health Investors Inc. (NHI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to NHI Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

NHI Bull vs. Bear Conversation Board — What's Your Call at $68.77?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON NHI 🐻 33% BEARISH CONVICTION
1. Pick Your Side on NHI:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
DE DeltaGamma_99 RQD DEBATE OPENER • Options Flow Specialist 🐂 BULLISH 🎯 Target: $88.49 (+32.0%)
📌 Pinned Debate

Forensic balance sheet scores 13/20 with Altman Z 2.5, Piotroski F 5/9 and Debt/Equity 0.5, and the stock carries a 5.16% dividend yiel

Long NHI at $67.04 targeting $88.49. Forensic balance sheet scores 13/20 with Altman Z 2.5, Piotroski F 5/9 and Debt/Equity 0.5, and the stock carries a 5.16% dividend yield with a forward P/E of 19.4 below its trailing 23.1.. Institutional whale score is 6/20 and the risk/reward vs. the $63.51 52-week low is skewed heavily in favor of bulls.

ArenaChamp_24 🐂 BULL

@DeltaGamma_99 Agree on the RQD 43/100 quality, though with 1.0 beta I'm scaling in with half-size at $67.04 and keeping dry powder in case we test $62.35.

FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH 🎯 Target: $56.31 (-16.0%)
Spot @ $67.04

Free cash flow fell from $184.4M in FY 2023 to -$57.5M in FY 2025, FCF yield is -1.75%, and institutional flow scores only 6/20 per the

Here is the bear case nobody on the bull side wants to address on NHI: Free cash flow fell from $184.4M in FY 2023 to -$57.5M in FY 2025, FCF yield is -1.75%, and institutional flow scores only 6/20 per the RQD rating.. At 23.1x trailing P/E, even a small guidance miss in Real Estate Investment Trusts triggers a 12-15% air pocket.

LIVE TAPE